Form 8-K - Current report:
SEC Accession No. 0001558370-21-012131
Filing Date
2021-08-30
Accepted
2021-08-30 17:15:32
Documents
12
Period of Report
2021-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20210830x8k.htm   iXBRL 8-K 31709
  Complete submission text file 0001558370-21-012131.txt   151267

Data Files

Seq Description Document Type Size
2 EX-101.SCH aytu-20210830.xsd EX-101.SCH 3031
3 EX-101.LAB aytu-20210830_lab.xml EX-101.LAB 16077
4 EX-101.PRE aytu-20210830_pre.xml EX-101.PRE 10208
5 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20210830x8k_htm.xml XML 4872
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 211224490
SIC: 2834 Pharmaceutical Preparations